TWO-SAMPLE CONTINUAL REASSESSMENT METHOD
From MaRDI portal
Publication:4244513
DOI10.1081/BIP-100100998zbMath0919.62123OpenAlexW1991092971WikidataQ41616151 ScholiaQ41616151MaRDI QIDQ4244513
Larry Zaiqian Shen, John O'Quigley, Anthony Gamst
Publication date: 5 September 1999
Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1081/bip-100100998
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05)
Related Items (12)
Patient-specific dose finding in phase I clinical trials ⋮ Efficiency of bridging between related dose finding studies ⋮ Continual reassessment and related dose-finding designs ⋮ Dose finding with escalation with overdose control (EWOC) in cancer clinical trials ⋮ Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control ⋮ Adaptive clinical trial designs for phase I cancer studies ⋮ A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate ⋮ Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates ⋮ Design efficiency in dose finding studies ⋮ Theoretical study of the continual reassessment method ⋮ Continual Reassessment Method for Ordered Groups ⋮ Individualized dosing for multiple ordered groups of patients
This page was built for publication: TWO-SAMPLE CONTINUAL REASSESSMENT METHOD
